{"product_id":"hbp-023","title":"Anti-Hepatitis B Virus Core Antigen, IgG Fraction, Polyclonal","description":"\u003cp\u003eAnti-hepatitis B-core IgG fraction is a polyclonal antibody raised in rabbit against purified recombinant hepatitis B-core . It is purified using Protein G.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This polyclonal antibody recognizes recombinant hepatitis B-core by Western analysis and ELISA.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e IgG fraction. Frozen liquid. 1.0 mg\/mL. Formulated in 0.1 M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hbp-023\"\u003ePublications using Austral Biologicals HBP-023-9\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HBP-023-9:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.2603476123\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHong et al., Proc Natl Acad Sci U S A 123(17):e2603476123 (2026).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/v18020187\" rel=\"noopener\" target=\"_blank\"\u003eDevelopment of a Novel Human Hepatoma Cell Line Supporting the Replication of a Recombinant HBV Genome with a Reporter Gene\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eKawase et al., Viruses 18(2):187 (2026).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1013776\" rel=\"noopener\" target=\"_blank\"\u003eNetrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWang et al., PLoS Pathog 21(12):e1013776 (2025).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1007\/s12072-025-10776-9\" rel=\"noopener\" target=\"_blank\"\u003eGut microbes associated with functional cure of chronic hepatitis B\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHonda et al., Hepatol Int 19(3):519-528 (2025).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.antiviral.2024.105821\" rel=\"noopener\" target=\"_blank\"\u003eAntiviral effect of peptoids on hepatitis B virus infection in cell culture\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMurayama et al., Antiviral Res 223:105821 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1097\/hc9.0000000000000206\" rel=\"noopener\" target=\"_blank\"\u003eFunctional involvement of endothelial lipase in hepatitis B virus infection\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eShirasaki et al., Hepatol Commun 7(9):e0206 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.21769\/bioprotoc.4779\" rel=\"noopener\" target=\"_blank\"\u003eProduction and Purification of Cell Culture-generated Hepatitis B Virus by Transient Transfection and Density Gradient\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMurayama et al., Bio Protoc 13(14):e4779 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1126\/sciadv.adg6265\" rel=\"noopener\" target=\"_blank\"\u003eAn RNA-based system to study hepatitis B virus replication and evaluate antivirals\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eYu et al., Sci Adv 9(15):eadg6265 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/mbio.03303-22\" rel=\"noopener\" target=\"_blank\"\u003eLive Cell Imaging Reveals HBV Capsid Translocation from the Nucleus To the Cytoplasm Enabled by Cell Division\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eRomero et al., mBio 14(2):e0330322 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.virusres.2022.199014\" rel=\"noopener\" target=\"_blank\"\u003eIdentification of neutralizing epitopes in the preS2 domain of the hepatitis B virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eYato et al., Virus Res 323:199014 (2023).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41467-022-32910-z\" rel=\"noopener\" target=\"_blank\"\u003eNeutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWashizaki et al., Nat Commun 13(1):5207 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.00767-21\" rel=\"noopener\" target=\"_blank\"\u003eMafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eIbrahim et al., J Virol 95(15):e0076721 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.chom.2020.05.010\" rel=\"noopener\" target=\"_blank\"\u003eA Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWang et al., Cell Host Microbe 28(2):335-349.e6 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1073\/pnas.1919035117\" rel=\"noopener\" target=\"_blank\"\u003eExpansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMichailidis et al., Proc Natl Acad Sci U S A 117(3):1678-1688 (2020).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/v11070651\" rel=\"noopener\" target=\"_blank\"\u003eEffects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral Replication\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePuray-Chavez et al., Viruses 11(7):E651 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1021\/acsinfecdis.8b00235\" rel=\"noopener\" target=\"_blank\"\u003eNovel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHuber et al., ACS Infect Dis 5(5):750-758 (2019).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/mspheredirect.00131-18\" rel=\"noopener\" target=\"_blank\"\u003eThe Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eHuber et al., mSphere 3(2):e00131-18 (2018).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41598-017-16882-5\" rel=\"noopener\" target=\"_blank\"\u003eA robust cell culture system supporting the complete life cycle of hepatitis B virus\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eMichailidis et al., Sci Rep 7(1):16616 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.01229-16\" rel=\"noopener\" target=\"_blank\"\u003eHepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eUnchwaniwala et al., J Virol 90(19):8705-8719 (2016).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jvi.03014-12\" rel=\"noopener\" target=\"_blank\"\u003eGenetically altering the thermodynamics and kinetics of hepatitis B virus capsid assembly has profound effects on virus replication in cell culture\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTan et al., J Virol 87(6):3208-3216 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HBP-023_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"1mg","offer_id":52517542428974,"sku":"HBP-023-9","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hbp-023-1mg.png?v=1788008629","url":"https:\/\/www.australbiologicals.com\/products\/hbp-023","provider":"Austral Biologicals","version":"1.0","type":"link"}